130
Participants
Start Date
March 14, 2019
Primary Completion Date
October 26, 2020
Study Completion Date
October 26, 2020
Edasalonexent
100 mg/kg/day
Royal Children's Hospital, Parkville
Children's Hospital of Philadelphia, Philadelphia
University of Hamburg, Hamburg
Kennedy Krieger Institute, Baltimore
Johns Hopkins School of Medicine, Baltimore
Rare Disease Research, LLC, Atlanta
Vanderbilt University Medical Center, Nashville
Queen Silvia Children's Hospital, Gothenburg
University of Michigan, Ann Arbor
University of Iowa Children's Hospital, Iowa City
University of Kansas Medical Center, Fairway
Cook Children's Medical Center, Fort Worth
University of Texas Health Science Center at San Antonio, San Antonio
University of Munich, Munich
University of Utah, Salt Lake City
Las Vegas Clinic, Las Vegas
UC Davis, Sacramento
Shriners Hospital for Children, Portland
Boston Children's Hospital, Boston
Children's Hospital of Eastern Ontario, Ottawa
Bristol Children's Hospital, Bristol
Great Ormond Street Hospital (GOSH), London
Royal Manchester Children's Hospital, Manchester
Lead Sponsor
Catabasis Pharmaceuticals
INDUSTRY